Histone Acetyltransferase MOF Orchestrates Outcomes at the Crossroad of Oncogenesis, DNA Damage Response, Proliferation, and Stem Cell Development

• Published in: Molecular and cellular biology Vol. 40; no. 18
• Main Authors: Singh, Mayank, Bacolla, Albino, Chaudhary, Shilpi, Hunt, Clayton R., Pandita, Shruti, Chauhan, Ravi, Gupta, Ashna, Tainer, John A., Pandita, Tej K.
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 28.08.2020; American Society for Microbiology
• Subjects: Acetylation; cancer; Carcinogenesis - metabolism; Cell Differentiation - physiology; Cell Nucleus - metabolism; Cell Proliferation - physiology; Cell Transformation, Neoplastic - metabolism; Chromatin - metabolism; DDR; DNA Damage; Embryonic Stem Cells - cytology; Embryonic Stem Cells - metabolism; Embryonic Stem Cells - physiology; histone acetyltransferase; Histone Acetyltransferases - metabolism; Histones - metabolism; Humans; Lung Neoplasms - metabolism; Minireview; MOF; Nuclear Proteins - metabolism; Protein Processing, Post-Translational; stem cell; cancer; DDR; stem cell; MOF; histone acetyltransferase
• ISSN: 1098-5549; 0270-7306; 1098-5549
• DOI: 10.1128/MCB.00232-20

The DNA and protein complex known as chromatin is subject to posttranslational modifications (PTMs) that regulate cellular functions such that PTM dysregulation can lead to disease, including cancer. One critical PTM is acetylation/deacetylation, which is being investigated as a means to develop targeted cancer therapies. The histone acetyltransferase (HAT) family of proteins performs histone acetylation. In humans, MOF (hMOF), a member of the MYST family of HATs, acetylates histone H4 at lysine 16 (H4K16ac). MOF-mediated acetylation plays a critical role in the DNA damage response (DDR) and embryonic stem cell development. Functionally, MOF is found in two distinct complexes: NSL (nonspecific lethal) in humans and MSL (male-specific lethal) in flies. The NSL complex is also able to acetylate additional histone H4 sites. Dysregulation of MOF activity occurs in multiple cancers, including ovarian cancer, medulloblastoma, breast cancer, colorectal cancer, and lung cancer. Bioinformatics analysis of KAT8, the gene encoding hMOF, indicated that it is highly overexpressed in kidney tumors as part of a concerted gene coexpression program that can support high levels of chromosome segregation and cell proliferation. The linkage between MOF and tumor proliferation suggests that there are additional functions of MOF that remain to be discovered.